Evaluation of antidepressant-like effects of curcumin phytosomes in chronic unpredictable mild stress-induced rat model
BIOCHEMICAL AND CELLULAR ARCHIVES · 21.03.2026 · 26 (1) · 423-434
DOI: 10.51470/bca.2026.26.1.423 ↗Kurz gefasst
Fachartikel in der Zeitschrift BIOCHEMICAL AND CELLULAR ARCHIVES, online erschienen am 25.03.2026. Verfasst von Pankaj Mohan Pimpalshinde und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Depression is a multifactorial neuropsychiatric disorder characterized by mood dysregulation, neurochemical imbalance and impaired neuroplasticity. The present study evaluated the antidepressant-like effects of curcumin phytosomes in a chronic unpredictable mild stress (CUMS)-induced rat model of depression. The animals were divided into five groups: Control, CUMS + Vehicle, CUMS + Curcumin (100 mg/kg), CUMS + Curcumin Phytosome (100 mg/kg) and CUMS + Fluoxetine (10 mg/kg). Behavioral parameters, including sucrose preference and immobility time in the forced swim and tail suspension tests, were assessed, followed by biochemical and histopathological analyses. Curcumin phytosome treatment significantly reversed CUMS-induced behavioral deficits, increased antioxidant enzyme levels (SOD, CAT, GPx), reduced lipid peroxidation and pro-inflammatory cytokines (IL-6, TNF-?) and normalized plasma corticosterone concentration. Additionally, curcumin phytosome enhanced hippocampal brain-derived neurotrophic factor (BDNF), CREB, and synaptophysin expression, indicating improved neuroplasticity. Histological studies revealed preserved hippocampal neuronal architecture in the phytosome-treated group, comparable to fluoxetine. These findings suggest that curcumin phytosome exerts antidepressant-like activity through modulation of the HPA axis, enhancement of monoaminergic transmission, reduction of oxidative stress and inflammation, and upregulation of neurotrophic factors. The study highlights curcumin phytosome as a potent, safe, and natural therapeutic candidate for managing depression. Curcumin phytosome represents a promising natural alternative or adjunct to conventional antidepressants, offering comparable efficacy with superior safety and tolerability. Its phytosomal delivery system effectively overcomes curcumin’s bioavailability limitations, ensuring better brain targeting and sustained therapeutic action. Further clinical validation is warranted to establish optimal dosage, long-term safety, and translational applicability in human depression therapy.
Zitieren
APA
Pimpalshinde, P. M., Ahmed, F., Mujawar, T., Bhaijamal, R. A., Tiwari, A., Sharma, S., Uplanchiwar, V. P., & Khokale, S. K. (2026). Evaluation of antidepressant-like effects of curcumin phytosomes in chronic unpredictable mild stress-induced rat model. BIOCHEMICAL AND CELLULAR ARCHIVES, 26(1), 423-434. https://doi.org/10.51470/bca.2026.26.1.423
Vancouver
Pimpalshinde PM, Ahmed F, Mujawar T, Bhaijamal RA, Tiwari A, Sharma S, et al. Evaluation of antidepressant-like effects of curcumin phytosomes in chronic unpredictable mild stress-induced rat model. BIOCHEMICAL AND CELLULAR ARCHIVES. 2026;26(1):423-434. doi:10.51470/bca.2026.26.1.423
BibTeX
@article{Pimpalshinde2026,
author = {Pimpalshinde, Pankaj Mohan and Ahmed, Firoz and Mujawar, Tabrej and Bhaijamal, Rizwan A and Tiwari, Anshu and Sharma, Shubham and Uplanchiwar, Vaibhav P. and Khokale, Sagar Kashinath},
title = {Evaluation of antidepressant-like effects of curcumin phytosomes in chronic unpredictable mild stress-induced rat model},
journal = {BIOCHEMICAL AND CELLULAR ARCHIVES},
year = {2026},
volume = {26},
number = {1},
pages = {423--434},
doi = {10.51470/bca.2026.26.1.423}
}
EUVIMED